In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating strong associations.
Introduction
In this issue, Hacker et al. contribute new data indicating how BRAF-mutant melanomas can be included in their previously proposed divergent pathway model for melanoma development. Their findings lend support to BRAF-mutant melanomas developing along a pathway positively associated with young age at diagnosis, high nevus counts, contiguous nevus remnants, and ability to tan, and inversely associated with evidence of high level of lifetime cumulative sun exposure. However, the authors found no association between germline melanocortin-1 receptor (MC1R) status and BRAF-mutant melanomas in an Australian population-based study. These results differ from two earlier publications (Fargnoli et al., 2008; Landi et al., 2006) that reported strong associations in three independent populations (two from Italy and one from San Francisco).
Divergent pathways
The results of Hacker et al. (2010, this issue) are concordant with many other studies that have demonstrated distinct risk factors for melanomas harboring BRAF mutations. Both hospital and population-based studies on different continents have found BRAF mutations to be associated with young age at diagnosis (Edlundh-Rose et al., 2006; Liu et al., 2007; Thomas et al., 2007) . Others have reported that BRAF-melanomas were associated with contiguous nevus remnants on histologic sections (EdlundhRose et al., 2006; Poynter et al., 2006) . Similar to the findings of Hacker et al. (2010) , BRAF-mutant melanomas have been reported to be associated with high back nevus counts and increased ability to tan in a North Carolina population-based study (Thomas et al., 2007) . Other studies have found BRAF-mutant melanomas to be inversely associated with chronically exposed anatomic site and solar elastosis, providing further evidence of an inverse association with high levels of cumulative sun exposure (Curtin et al., 2005) .
Paradox and possible explanations
Hacker et al. (2010) report no association between germline MC1R variants and BRAF-mutant melanomas in 123 cases from Australia. Similarly, we examined the relationship between MC1R status and BRAF-mutant melanomas in our North Carolina population-based study, and, like those of Hacker and colleagues, our results do not support a strong association (unpublished data). In contrast, Landi et al. (2006) scored independent sets of 86 and 112 melanoma specimens from a case-control study in Italy and a hospital-based series in San Francisco for histologic evidence of chronic sun damage (CSD). The majority, 56 and 58, respectively, did not show CSD. They reported that MC1R variants were strongly associated with BRAF-mutant melanomas in biopsies with little histologic evidence of chronic sun damage (non-CSD) (Landi et al., 2006) . More recently, in a separate case-control study in Italy that included 92 melanomas typed for BRAF mutations, Fargnoli et al. (2008) also reported germline MC1R variants to be strongly associated with BRAFmutations, independent of CSD status.
There are several possible explanations for the different results among these studies. First, dissimilar estimates may be due, in part, to unique effects of specific MC1R variants, the frequencies of which differ somewhat among study populations. Second, there may be unidentified genotypic variation among populations that affects the association of MC1R variants with BRAF-mutant melanoma. For example, inherited variants in other genes related to pigmentation, tanning response, or nevus propensity might influence this association. Furthermore, environmental differences, in particular ambient sun exposure, could affect the relationship.
Gene-environment and gene-gene interactions involving MC1R could be www.jidonline.org 13 pigmentation might be expected to have less influence on eumelanin production in these individuals. Increased statistical power, along with ample representation of different populations, including those with different European ancestries, should help to solve this problem. This work could be approached through larger studies or meta-analyses including diverse populations. Genome-wide association and candidate pathway studies to identify and assess additional inherited melanoma risk factors should provide complementary information. Genotypic variants may be found that are associated with BRAF-mutations or that modify the relationship between MC1R variants and BRAF mutations in melanoma. Candidate pathways of interest include those that affect pigment phenotype, tanning response, nevus propensity, and DNA damage response. An increased ability to assign inherited differences and somatic alterations in melanoma to pathways in the divergent pathway model of melanoma development should improve our understanding of melanoma risk and may lead to better risk prediction and targeted prevention.
CONFLICT OF INTEREST
The authors state no conflict of interest. et al., 2001; Palmer et al., 2000) .
ACKNOWLEDGMENTS
Because all studies to date examining the association of MC1R variants with BRAF-mutant melanoma are relatively small, we cannot rule out the possibility that the differences in results are attributable to chance alone and that further investigation with larger populations will clarify the relationship. In addition, few MC1R "R/R" participants have been represented in studies to date, making it difficult to assess the odds of BRAF-mutant melanoma in individuals who would be likely to have very low eumelanin levels and simultaneously decreased DNA damage responses due to their MC1R status. Other genes that regulate tanning responses or quite complex because MC1R functional status alone might have opposing effects on the risk of BRAF-mutant melanoma, as shown in Figure 1 . In this model, we assume that basal pheomelanin production is the null phenotype of MC1R and that epidermal pheomelanin levels do not vary among the groups based on findings that MC1R mutations reduce eumelanin but do not change pheomelanin concentration in mouse tail epidermis (Van Raamsdonk et al., 2009) . Inheritance of decreased-function MC1R variants might increase the risk of BRAF-mutant melanoma through diminished constitutive and facultative pigmentation, less effective DNA damage response mechanisms, and increased generation of hydrogen peroxide (Abdel-Malek et al., 2008) . However, carriage of functional MC1R alleles might increase risk because eumelanin, as well as pheomelanin, can contribute to oxidative stress (Meyskens et al., 2004) , and individuals with more eumelanin may increase their sun exposure because of their relatively decreased sun sensitivity.
Because of these competing effects, it is possible that genotypes with an intermediate loss of MC1R function might produce a favorable host phenotype for production of BRAF-mutant nevi and melanoma. A combination of some eumelanin and decreased DNA damage responses may be most conducive to increased risk of BRAF mutations. Concordant with this possibility is the finding that blue-eyed individuals with more than one strong MC1R red hair variant ("R/R"), as defined by Duffy et al. (2004) , tend to have fewer nevi, which Functional MC1R allows the production of the darker eumelanin pigment and the tanning response. Carriage of decrease-of-function MC1R variants may allow increased BRAF-mutated melanoma risk through decreased photoprotection by eumelanin and attenuation of DNA damage response mechanisms. In opposition, more functional MC1R alleles may increase risk through increased eumelanin, leading to more oxidative stress and increased sun exposure due to decreased sun sensitivity. In the late 1980s and early 1990s, Schartl and colleagues published work that associated an EGFR-related gene, Xmrk, with the sex-linked Mdl locus (then called Tu). The molecular cloning and characterization of this oncogenic melanoma receptor kinase revolutionized the study of the Xiphophorus melanoma model and strengthened the concept of Xmrk as a dominant oncogene in the model, with R playing the role of a recessive tumor suppressor. The true identity of R has proven elusive, because the cloned candidate for this susceptibility locus, a homolog of the CDKN2 family called CDKN2AB, does not behave as predicted for a recessive tumor suppressor. However, a number of complexities are revealed by studying other hybrid crosses available in Xiphophorus, and it is possible that R may be playing the role of a modifier of Xmrk activity rather than a frank suppressor, at least within Xiphophorus interspecies hybrids (see Butler et al., 2007 , for a discussion of this point). In any event, there is abundant evidence that Xmrk can behave as a dominant oncogene, specifically overexpressed in pigmented tissue and driving oncogenesis. In this issue, Schartl and colleagues express Xmrk as a transgene in the pigmented tissues of a fish other than Xiphophorus, called medaka, and demonstrate conclusively that this gene is a powerful and dominant oncogene driving melanoma formation (Figure 1 
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Xmrk, Xiphophorus, and melanoma genetics
Fish have long been used in biomedical research and are increasingly used as models of human disease. Fish can develop a wide range of cancers, including neurofibromatosis, hematological and liver cancers, and melanoma, among others (Bunton, 1996) . The Xiphophorus hybrid melanoma was recognized in the 1920s as a genetically controlled tumor model and has been studied since then (Meierjohann and Schartl, 2006) . In this melanoma model, interspecies hybrids between pigmented platyfish (Xiphophorus maculatus) and
